Fluorodeoxyglucose positron emission tomography of mild cognitive impairment with clinical follow-up at three years

BACKGROUND: Alzheimer’s disease (AD) is the most common dementing illness. Development of effective treatments directed at AD requires an early diagnosis. Mild cognitive impairment (MCI) often heralds AD. Thus, characterizing MCI is fundamental to the early diagnosis of AD. PARTICIPANTS: Nineteen MC...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Pardo, José V., Lee, Joel T., Kuskowski, Michael A., Munch, Kristin R., Carlis, John V., Sheikh, Sohail A., Surerus, Christa, Lewis, Scott M., McCarten, J. Riley, Fink, Howard, McPherson, Susan, Shah, Hemant H., Rottunda, Susan, Dysken, Maurice W.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2010
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2918397/
https://ncbi.nlm.nih.gov/pubmed/20447873
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jalz.2009.09.005
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares